Skip to main content

Advertisement

SpringerLink
Log in

The synergistic role of TNFA − 308G/A and IL10 − 1082A/G polymorphisms in ankylosing spondylitis

  • Genes and Disease
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Objective

Genetic polymorphisms of the cytokine genes could alter their protein expression, thus creating a genetic basis of dysregulated cytokine production and function, which render them as excellent candidates predisposing to autoimmune diseases. We investigated single nucleotide polymorphisms (SNPs) at TNFA − 308G/A and IL10 − 1082A/G locus to identify their involvement, separately or in combination, in determining susceptibility to ankylosing spondylitis (AS), as well as their functional connections with relevant serum cytokines and associations with disease characteristics.

Methods

Eighty-one AS patients and 215 healthy controls were genotyped by polymerase chain reaction-based method; 76 patients and sex-matched controls were also subjected to analysis of serum TNF-α and IL-10 levels by enzyme-linked immunosorbent assay.

Results

We identified the homozygous genotype GG of the TNFA–308 significantly more common in patients than controls; whereas the − 308 minor A-allele predicts a threefold decreased risk against developing AS and shows associations with milder radiographic spinal impairments and functional limitations. This protective effect was multiplied by fivefold in synergistic interaction with the homozygous − 1082AA genotype of the IL10 which acts as a modifying factor, since IL10 − 1082A/G SNPs by itself did not have a significant impact on AS genetic susceptibility. In comparison with controls, AS patients had significantly elevated mean serum TNF-α levels and decreased mean IL-10 concentrations not restricted to any particular genotype.

Conclusion

TNFA − 308 A-allele is essential for reducing susceptibility to AS, with a considerable synergistic protective effect of the combined TNF-α − 308 (GA/AA)/IL-10 − 1082AA genotypes. In addition, the presence of this variant allele is associated with more benign clinical phenotype of the disease. No conclusive statements on the functional relevance of both gene variants on cytokines production should be made.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369(9570):1379–1390. https://doi.org/10.1016/S0140-6736(07)60635-7

    Article  PubMed  Google Scholar 

  2. Jethwa H, Bowness P (2016) The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment. Clin Exp Immunol 183(1):30–36. https://doi.org/10.1111/cei.12670

    Article  CAS  PubMed  Google Scholar 

  3. Cuthbert RJ, Fragkakis EM, Dunsmuir R, Li Z, Coles M, Marzo-Ortega H, Giannoudis PV, Jones E, El-Sherbiny YM, McGonagle D (2017) Brief report: group 3 innate lymphoid cells in human enthesis. Arthr Rheumatol 69:1816–1822. https://doi.org/10.1002/art.40150

    Article  CAS  Google Scholar 

  4. Taylan A, Sari I, Kozaci DL, Yuksel A, Bilge S, Yildiz Y, Sop G, Coker I, Gunay N, Akkoc N (2012) Evaluation of the T helper 17 axis in ankylosing spondylitis. Rheumatol Int 32(8):2511–2515. https://doi.org/10.1007/s00296-011-1995-7

    Article  CAS  PubMed  Google Scholar 

  5. Watad A, Bridgewood C, Russell T, Marzo-Ortega H, Cuthbert R, McGonagle D (2018) The early phases of ankylosing spondylitis: emerging insights from clinical and basic science. Front Immunol 9:2668. https://doi.org/10.3389/fimmu.2018.02668

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Wang X, Lin Z, Wei Q, Jiang Y, Gu J (2009) Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatol Int 29(11):1343–1347. https://doi.org/10.1007/s00296-009-0883-x

    Article  CAS  PubMed  Google Scholar 

  7. Davis JC Jr (2005) Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis. Semin Arthritis Rheum 34(4):668–677. https://doi.org/10.1016/j.semarthrit.2004.08.005

    Article  CAS  PubMed  Google Scholar 

  8. Elahi MM, Asotra K, Matata BM, Mastana SS (2009) Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta 1792(3):163–172. https://doi.org/10.1016/j.bbadis.2009.01.007

    Article  CAS  PubMed  Google Scholar 

  9. Gratacos J, Collado A, Filella X, Sanmarti R, Canete J, Llena J, Molina R, Ballesta A, Muñoz-Gómez J (1994) Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 33(10):927–931. https://doi.org/10.1093/rheumatology/33.10.927

    Article  CAS  PubMed  Google Scholar 

  10. Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, Eggens U, Distler A, Sieper J (1995) Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38(4):499–505. https://doi.org/10.1002/art.1780380407

    Article  CAS  PubMed  Google Scholar 

  11. Maas F, Arends S, Brouwer E, Essers I, van der Veer E, Efde M, van Ooijen PMA, Wolf R, Veeger NJGM, Bootsma H, Wink FR, Spoorenberg A (2017) Reduction in spinal radiographic progression in ankylosing spondylitis patients receiving prolonged treatment with tumor necrosis factor inhibitors. Arthritis Care Res (Hoboken) 69(7):1011–1019. https://doi.org/10.1002/acr.23097

    Article  CAS  Google Scholar 

  12. Nedwin GE, Naylor SL, Sakaguchi AY, Smith D, Jarrett-Nedwin J, Pennica D, Goeddel DV, Gray PW (1985) Human lymphotoxin and tumor necrosis factor gene: structure, homology and chromosomal localization. Nucleic Acids Res 13:6361–6373. https://doi.org/10.1093/nar/13.17.6361

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Verweij CL (1999) Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis. Ann Rheum Dis 58:I20–I26. https://doi.org/10.1136/ard.58.2008.i20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. El-Tahan RR, Ghoneim AM, El-Mashad N (2016) TNF-α gene polymorphisms and expression. Springerplus 5(1):1508. https://doi.org/10.1186/s40064-016-3197-y

    Article  PubMed  PubMed Central  Google Scholar 

  15. Lee YH, Song GG (2009) Lack of association of TNF-alpha promoter polymorphisms with ankylosing spondylitis: a meta-analysis. Rheumatology (Oxford) 48(11):1359–1362. https://doi.org/10.1093/rheumatology/kep260

    Article  CAS  Google Scholar 

  16. Li B, Wang P, Li H (2010) The association between TNF-alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis. Clin Rheumatol 29(9):983–990. https://doi.org/10.1007/s10067-010-1499-y

    Article  CAS  PubMed  Google Scholar 

  17. Poddubnyy DA, Märker-Hermann E, Kaluza-Schilling W, Zeidler H, Braun J, Listing J, Sieper J, Rudwaleit M (2011) Relation of HLA-B27, tumor necrosis factor-α promoter gene polymorphisms, and T cell cytokine production in ankylosing spondylitis—a comprehensive genotype-phenotype analysis from an observational cohort. J Rheumatol 38(11):2436–2441. https://doi.org/10.3899/jrheum.110130

    Article  CAS  PubMed  Google Scholar 

  18. Vargas-Alarcón G, Casasola-Vargas J, Rodríguez-Pérez JM, Huerta-Sil G, Pérez Hernández N, Londoño J, Pacheco-Tena C, Cardiel MH, Granados J, Burgos-Vargas R (2006) Tumor necrosis factor-α promoter polymorphisms in mexican patients with spondyloarthritis. Hum Immunol 67:826–832. https://doi.org/10.1016/j.humimm.2006.07.009

    Article  CAS  PubMed  Google Scholar 

  19. Shiau M-Y, Lo M-K, Chang C-P, Yang T-P, Ho K-T, Chang Y-H (2007) Association of tumour necrosis factor α promoter polymorphisms with ankylosing spondylitis in Taiwan. Ann Rheum Dis 66:562–563. https://doi.org/10.1136/ard.2006.065888

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Moore KW, de Waal MR, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765. https://doi.org/10.1146/annurev.immunol.19.1.683

    Article  CAS  PubMed  Google Scholar 

  21. Saraiva M, O’Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170–181. https://doi.org/10.1038/nri2711

    Article  CAS  PubMed  Google Scholar 

  22. de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174(5):1209–1220. https://doi.org/10.1084/jem.174.5.1209

    Article  Google Scholar 

  23. Iyer SS, Cheng G (2012) Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 32:23–63. https://doi.org/10.1615/critrevimmunol.v32.i1.30

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Liu P, Song J, Su H, Li L, Lu N, Yang R, Peng Z (2013) IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis. PLoS ONE 8(7):e69547. https://doi.org/10.1371/journal.pone.0069547.t003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Van der Linden SM, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368. https://doi.org/10.1002/art.1780270401

    Article  PubMed  Google Scholar 

  26. Manolova I, Miteva L, Ivanova M, Kundurzhiev T, Stoilov R, Stanilova S (2018) The synergistic effect of TNFA and IL10 promoter polymorphisms on genetic predisposition to systemic Lupus Erythematosus. Genet Test Mol Biomark 22(2):135–140. https://doi.org/10.1089/gtmb.2017.0169

    Article  CAS  Google Scholar 

  27. Manolova I, Ivanova M, Stoilov R, Rashkov R, Stanilova S (2014) Association of single nucleotide polymorphism at position -308 of the tumor necrosis factor-alpha gene with ankylosing spondylitis and rheumatoid arthritis. Biotechnol Equip 28(6):1108–1114. https://doi.org/10.1080/13102818.2014.972147

    Article  CAS  Google Scholar 

  28. Hohler T, Schaper T, Schneider PM, Meyer ZBK, Marker-Hermann E (1998) Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 41:1489−1492. https://doi.org/10.1002/1529-0131(199808)41:8<1489::AID-ART20>3.0.CO;2-5

  29. McGarry F, Walker R, Sturrock R, Field M (1999) The −308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J Rheumatol 26:1110–1116

    CAS  PubMed  Google Scholar 

  30. Nossent JC, Sagen-Johnsen S, Bakland G (2014) Tumor necrosis factor-α promoter -308/238 polymorphism association with less severe disease in ankylosing spondylitis is unrelated to serum TNF-α and does not predict TNF inhibitor response. J Rheumatol 41(8):1675–1682. https://doi.org/10.3899/jrheum.131315

    Article  CAS  PubMed  Google Scholar 

  31. Rudwaleit M, Siegert S, Yin Z, Eick J, Thiel A, Radbruch A, Sieper J, Braun J (2001) Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF–308 gene polymorphism. Ann Rheum Dis 60:36–42. https://doi.org/10.1136/ard.60.1.36

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Bal A, Unlu E, Bahar G, Aydog E, Eksioglu E, Yorgancioglu R (2007) Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis. Clin Rheumatol 26:211–215. https://doi.org/10.1007/s10067-006-0283-5

    Article  CAS  PubMed  Google Scholar 

  33. Lv C, Wang Y, Wang J, Zhang H, Xu H, Zhang D (2011) Association of Interleukin-10 gene polymorphisms with ankylosing spondylitis. Clin Invest Med 34(6):E370. https://doi.org/10.25011/cim.v34i6.15898

    Article  CAS  PubMed  Google Scholar 

  34. Braga M, Lara-Armi FF, Neves JSF, Rocha-Loures MA, Terron-Monich MS, Bahls-Pinto LD, Lima Neto QA, Zacarias JMV, Sell AM, Visentainer JEL (2021) Influence of IL10 (rs1800896) polymorphism and TNF-a, IL-10, IL-17A, and IL-17F serum levels in ankylosing spondylitis. Front Immunol 12:653611. https://doi.org/10.3389/fimmu.2021.653611

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafé M, Cavallone L, Marchegiani F, Olivieri F, Franceschi C, Caruso C (2003) Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP. J Med Genet 40(4):296–299. https://doi.org/10.1136/jmg.40.4.296

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinic of Rheumatology, University Hospital “St. Ivan Rilski”, Medical Faculty, Medical University, 13, Urvich St., Sofia, 1612, Bulgaria

    Mariana Ivanova & Rumen Stoilov

  2. Department of Molecular Biology, Immunology and Medical Genetics, Medical Faculty, Trakia University, Stara Zagora, Bulgaria

    Irena Manolova & Spaska Stanilova

Authors
  1. Mariana Ivanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Irena Manolova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rumen Stoilov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Spaska Stanilova
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization: SS, IM. Data curation: SS, IM, MI. Formal analysis: IM. Investigation: MI, IM, RS, SS. Methodology: SS, IM. Resources: MI, RS. Validation: SS. Writing ± original draft: MI. Writing ± review and editing: MI, IM, RS, SS.

Corresponding author

Correspondence to Mariana Ivanova.

Ethics declarations

Conflict of interest

Author Mariana Ivanova declares that she has no conflict of interest. Author Irena Manolova declares that she has no conflict of interest. Author Rumen Stoilov declares that he has no conflict of interest. Author Spaska Stanilova declares that she has no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ivanova, M., Manolova, I., Stoilov, R. et al. The synergistic role of TNFA − 308G/A and IL10 − 1082A/G polymorphisms in ankylosing spondylitis. Rheumatol Int 41, 2215–2224 (2021). https://doi.org/10.1007/s00296-021-04984-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-021-04984-3

Keywords

Search

Navigation